BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11827204)

  • 1. Binding inhibition of type 1 fimbriae to human granulocytes: a flow cytometric inhibition assay using trivalent cluster mannosides.
    Horst AK; Kötter S; Lindhorst TK; Ludwig A; Brandt E; Wagener C
    Med Microbiol Immunol; 2001 Dec; 190(3):145-9. PubMed ID: 11827204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bi- and trivalent glycopeptide mannopyranosides as inhibitors of type 1 fimbriae-mediated bacterial adhesion: variation of valency, aglycon and scaffolding.
    Schierholt A; Hartmann M; Lindhorst TK
    Carbohydr Res; 2011 Sep; 346(12):1519-26. PubMed ID: 21645881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic multimeric heptyl mannosides as potent antiadhesives of uropathogenic Escherichia coli.
    Gouin SG; Wellens A; Bouckaert J; Kovensky J
    ChemMedChem; 2009 May; 4(5):749-55. PubMed ID: 19343765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of adhesion of type 1 fimbriated Escherichia coli to highly mannosylated ligands.
    Nagahori N; Lee RT; Nishimura S; Pagé D; Roy R; Lee YC
    Chembiochem; 2002 Sep; 3(9):836-44. PubMed ID: 12210984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells.
    Firon N; Ashkenazi S; Mirelman D; Ofek I; Sharon N
    Infect Immun; 1987 Feb; 55(2):472-6. PubMed ID: 3542836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of type 1 fimbriae-mediated Escherichia coli adhesion and biofilm formation by trimeric cluster thiomannosides conjugated to diamond nanoparticles.
    Khanal M; Larsonneur F; Raks V; Barras A; Baumann JS; Martin FA; Boukherroub R; Ghigo JM; Ortiz Mellet C; Zaitsev V; Garcia Fernandez JM; Beloin C; Siriwardena A; Szunerits S
    Nanoscale; 2015 Feb; 7(6):2325-35. PubMed ID: 25559389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Mannopyranoside Therapeutics against Adherent-Invasive Escherichia coli Infections.
    Mousavifar L; Touaibia M; Roy R
    Acc Chem Res; 2018 Nov; 51(11):2937-2948. PubMed ID: 30289687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolylaminomannosides as potent antiadhesives of type 1 piliated Escherichia coli isolated from Crohn's disease patients.
    Brument S; Sivignon A; Dumych TI; Moreau N; Roos G; Guérardel Y; Chalopin T; Deniaud D; Bilyy RO; Darfeuille-Michaud A; Bouckaert J; Gouin SG
    J Med Chem; 2013 Jul; 56(13):5395-406. PubMed ID: 23795713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ortho-Substituted α-Phenyl Mannoside Derivatives Promoted Early-Stage Adhesion and Biofilm Formation of
    Zhu Z; Chen Y; Li S; Lin H; Qin G; Cai C
    ACS Appl Mater Interfaces; 2020 May; 12(19):21300-21310. PubMed ID: 32107915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of Escherichia coli and Salmonella strains to members of the carcinoembryonic antigen family: differential binding inhibition by aromatic alpha-glycosides of mannose.
    Leusch HG; Drzeniek Z; Markos-Pusztai Z; Wagener C
    Infect Immun; 1991 Jun; 59(6):2051-7. PubMed ID: 1674739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of cluster mannosides via a Ugi four-component reaction and their inhibition against the binding of yeast mannan to concanavalin A.
    Li Y; Zhang X; Chu S; Yu K; Guan H
    Carbohydr Res; 2004 Mar; 339(4):873-9. PubMed ID: 14980831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes.
    Bouckaert J; Mackenzie J; de Paz JL; Chipwaza B; Choudhury D; Zavialov A; Mannerstedt K; Anderson J; Piérard D; Wyns L; Seeberger PH; Oscarson S; De Greve H; Knight SD
    Mol Microbiol; 2006 Sep; 61(6):1556-68. PubMed ID: 16930149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonlethal adherence to human neutrophils mediated by Dr antigen-specific adhesins of Escherichia coli.
    Johnson JR; Skubitz KM; Nowicki BJ; Jacques-Palaz K; Rakita RM
    Infect Immun; 1995 Jan; 63(1):309-16. PubMed ID: 7806371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Antiadhesive Strategy in Crohn's Disease: Orally Active Mannosides to Decolonize Pathogenic Escherichia coli from the Gut.
    Alvarez Dorta D; Sivignon A; Chalopin T; Dumych TI; Roos G; Bilyy RO; Deniaud D; Krammer EM; de Ruyck J; Lensink MF; Bouckaert J; Barnich N; Gouin SG
    Chembiochem; 2016 May; 17(10):936-52. PubMed ID: 26946458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of a 60-kilodalton D-mannose-containing salivary glycoprotein with type 1 fimbriae of Escherichia coli.
    Babu JP; Abraham SN; Dabbous MK; Beachey EH
    Infect Immun; 1986 Oct; 54(1):104-8. PubMed ID: 2875948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sites for Dynamic Protein-Carbohydrate Interactions of O- and C-Linked Mannosides on the E. coli FimH Adhesin.
    Touaibia M; Krammer EM; Shiao TC; Yamakawa N; Wang Q; Glinschert A; Papadopoulos A; Mousavifar L; Maes E; Oscarson S; Vergoten G; Lensink MF; Roy R; Bouckaert J
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28671638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides.
    Han Z; Pinkner JS; Ford B; Chorell E; Crowley JM; Cusumano CK; Campbell S; Henderson JP; Hultgren SJ; Janetka JW
    J Med Chem; 2012 Apr; 55(8):3945-59. PubMed ID: 22449031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basement membrane carbohydrate as a target for bacterial adhesion: binding of type I fimbriae of Salmonella enterica and Escherichia coli to laminin.
    Kukkonen M; Raunio T; Virkola R; Lähteenmäki K; Mäkelä PH; Klemm P; Clegg S; Korhonen TK
    Mol Microbiol; 1993 Jan; 7(2):229-37. PubMed ID: 8095317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligomannoside mimetics by glycosylation of 'octopus glycosides' and their investigation as inhibitors of type 1 fimbriae-mediated adhesion of Escherichia coli.
    Dubber M; Sperling O; Lindhorst TK
    Org Biomol Chem; 2006 Nov; 4(21):3901-12. PubMed ID: 17047869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shigella flexneri transformants expressing type 1 (mannose-specific) fimbriae bind to, activate, and are killed by phagocytic cells.
    Gbarah A; Mirelman D; Sansonetti PJ; Verdon R; Bernhard W; Sharon N
    Infect Immun; 1993 May; 61(5):1687-93. PubMed ID: 8097492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.